Study to Validate Simple Acute Coronary Syndrome Score (SACS Score)
Recruitment status was: Enrolling by invitation
The Simple Acute Coronary Syndrome (SACS) Score was developed as a Risk Stratification Tool for Acute Coronary Syndrome (ACS). It is a tool which rates a patient's: SYMPTOMS, EKG FINDINGS, RISK FACTOR PROFILE, and CARDIAC MARKERS on a scale of zero to six.
The purpose of this study is to validate the SACS Scoring tool by establishing a correlation between the score's numerical values and the degree of obstructive cardiovascular disease visualized during cardiac catheterization.
Acute Coronary Syndrome
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||Phase 1 - Pilot Study to Validate the Simple Acute Coronary Syndrome Score; an Acute Coronary Syndrome (ACS) Risk Stratification Tool|
- PRESENCE or ABSENCE of obstructive CAD as discovered during non-investigative coronary angiography in the Cardiac Catheterization Lab. [ Time Frame: Within 24 hours of: a) arrival in Emergency Department, or b) admission to the hospital ]
|Study Start Date:||August 2009|
|Estimated Study Completion Date:||June 2014|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
1. Patients with symptoms of ACS
Patients whom present emergently to the Cardiac Catheterization Lab with current symptoms of Acute Coronary Syndrome (ACS), whom at the time of admission to the cardiac catheterization lab are believed to be suffering from STEMI, NSTEMI, or Unstable Angina, with the possible need for emergency Percutaneous Coronary Intervention (PCI), or Coronary Artery Bypass Grafting (CABG).
2. Patients without symptoms of ACS
Non-emergency patients presenting to the Cardiac Catheterization Lab for elective coronary angiography, and possible PCI. These are patients whom may have experienced typical or atypical ACS symptoms intermittently, and have elected to have cardiac catheterization to rule out obstructive CAD. Patients in this group will be selected randomly, with consent obtained, prior to cardiac catheterization.
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT00947804
|United States, Florida|
|St. Joseph's Hospital|
|Tampa, Florida, United States, 33607|
|Principal Investigator:||Wayne W Ruppert, CVT||St. Joseph's Hospital, Tampa, FL|
|Study Director:||Humberto Coto, MD, FACC||St. Joseph's Hostpial, Tampa, Florida|
|Study Director:||Xavier E Prida, MD, FACC||St. Joseph's Hospital, Tampa, Florida|
|Study Director:||Charles Sand, MD, FACEP||St. Joesph's Hospital, Tampa, FL|